Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein-Reference-Cited by-同舟云学术

Application of transmesenteric vein extrahepatic portosystemic shunt in treatment of symptomatic portal hypertension with cavernous transformation of portal vein

Published:2023-05 Issue:2 Volume:6 Page:90-95
ISSN:2096-3602
Container-title:Journal of Interventional Medicine
language:en
Short-container-title:Journal of Interventional Medicine

Author:

Li Weixiao,Cui Mingzhe,Li Qiang,Zhang Kewei,Zhai Shuiting,Li Tianxiao,Nick Cheshire,Li Xiuling,Wang Heng,Zhu Yadong,Lu Danghui,Chen Jiangbo

Funder

Henan Provincial Science and Technology Research Project

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study;Nery;Hepatology,2015

2. EASL clinical practice guidelines: vascular diseases of the liver;J Hepatol,2016

3. Splenectomy causes 10-fold increased risk of portal venous system thrombosis in liver cirrhosis patients;Qi;Med Sci Monit,2016

4. Cavernous transformation of the portal vein: a cause of thrombocytopenia and splenomegaly;Klopfenstein;Clin Pediatr,2000

5. Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children;Lautz;J Am Coll Surg,2013

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of precision-guided transjugular extrahepatic portosystemic shunt (TEPS) in the management of cavernous transformation of the portal vein with portal hypertension: a case series;Hepatology International;2024-04-09